Skip to main content
. Author manuscript; available in PMC: 2022 Feb 16.
Published in final edited form as: Clin Trials. 2021 Nov 29;19(1):86–96. doi: 10.1177/17407745211046672

Table 4.

Conduct and reporting of sample size or power calculations (N=62)

Characteristic Frequency (%)

Sample size / power calculations presented?
 Yesa 50 (80.6%)
 No 12 (19.4%)

Did sample size / power calculation account for clustering?
Cluster randomized trial (N=38)
 Yes: Participant-level accounting for clustering 20 (52.6%)
 Yes: Cluster-level 2 (5.3%)
 No: Participant -level without accounting for clustering 5 (13.2%)
 Unclear whether accounted for clustering 1 (2.6%)
 No sample size calculation presented 10 (26.3%)
Individually randomized group treatment trial (N=9)
 Yes: Participant-level accounting for clustering 3 (33.3%)
 No: Participant -level without accounting for clustering 6 (66.7%)
 No sample size calculation presented 0

Did sample size/ power calculation account for repeated measures? (N=54)
 Yes 9 (16.7%)
 No 33 (61.1%)
 No sample size calculation presented 12 (22.2%)

Was correlation in dyadic or multivariate outcome accounted for in sample size calculation? (N=17)
 Yes 0
 No 12 (70.6%)
 No sample size calculation presented 5 (29.4%)
a

Includes one trial presenting a sample size calculation based on an unspecified outcome